The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AC IMMUNE SA | SHS | H00263105 | 869 | 274,876 | SH | SOLE | 274,876 | 0 | 0 | ||
ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | 108,608 | 1,389,200 | SH | SOLE | 1,389,200 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 106,304 | 3,122,000 | SH | SOLE | 3,122,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 57,746 | 288,500 | SH | SOLE | 288,500 | 0 | 0 | ||
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 14,989 | 1,715,000 | SH | SOLE | 1,715,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 7,190 | 998,600 | SH | SOLE | 998,600 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 34,275 | 2,684,000 | SH | SOLE | 2,684,000 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 12,907 | 742,630 | SH | SOLE | 742,630 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 57,645 | 844,000 | SH | SOLE | 844,000 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 15,183 | 794,500 | SH | SOLE | 794,500 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 173,630 | 491,800 | SH | SOLE | 491,800 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 41,490 | 1,255,374 | SH | SOLE | 1,255,374 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 193,242 | 4,343,500 | SH | SOLE | 4,343,500 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 4,955 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 30,886 | 563,200 | SH | SOLE | 563,200 | 0 | 0 | ||
AVANTOR INC | COM | 05352A100 | 88,643 | 4,522,600 | SH | SOLE | 4,522,600 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 42,458 | 2,600,000 | SH | SOLE | 2,600,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 68,652 | 1,538,600 | SH | SOLE | 1,538,600 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 5,010 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 17,796 | 132,000 | SH | SOLE | 132,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 45,901 | 4,346,700 | SH | SOLE | 4,346,700 | 0 | 0 | ||
BIO RAD LABS INC | CL A | 090572207 | 60,402 | 144,800 | SH | SOLE | 144,800 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 160,200 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 98,320 | 2,538,600 | SH | SOLE | 2,538,600 | 0 | 0 | ||
CAREMAX INC | COM CL A | 14171W103 | 5,355 | 755,329 | SH | SOLE | 755,329 | 0 | 0 | ||
CARIBOU BIOSCIENCES INC | COM | 142038108 | 33,471 | 3,172,600 | SH | SOLE | 3,172,600 | 0 | 0 | ||
CATALENT INC | COM | 148806102 | 68,018 | 940,000 | SH | SOLE | 940,000 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 33,645 | 432,400 | SH | SOLE | 432,400 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 12,893 | 1,303,600 | SH | SOLE | 1,303,600 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 20,257 | 1,357,700 | SH | SOLE | 1,357,700 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 4,560 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 3,468 | 1,806,200 | SH | SOLE | 1,806,200 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 16,231 | 335,000 | SH | SOLE | 335,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 22,048 | 1,191,800 | SH | SOLE | 1,191,800 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 37,661 | 467,600 | SH | SOLE | 467,600 | 0 | 0 | ||
ELEVANCE HEALTH INC | COM | 036752103 | 94,300 | 207,600 | SH | SOLE | 207,600 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 7,664 | 982,500 | SH | SOLE | 982,500 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 4,477 | 2,460,000 | SH | SOLE | 2,460,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 17,371 | 1,450,000 | SH | SOLE | 1,450,000 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 4,993 | 1,575,000 | SH | SOLE | 1,575,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,960 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 91,733 | 1,482,200 | SH | SOLE | 1,482,200 | 0 | 0 | ||
HUMANA INC | COM | 444859102 | 102,860 | 212,000 | SH | SOLE | 212,000 | 0 | 0 | ||
HYPERFINE INC | COM CL A | 44916K106 | 1,218 | 1,503,754 | SH | SOLE | 1,503,754 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 55,434 | 3,715,400 | SH | SOLE | 3,715,400 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 97,593 | 2,079,100 | SH | SOLE | 2,079,100 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 55,910 | 999,100 | SH | SOLE | 999,100 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 65,258 | 1,402,500 | SH | SOLE | 1,402,500 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 13,248 | 1,382,900 | SH | SOLE | 1,382,900 | 0 | 0 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 42,426 | 318,300 | SH | SOLE | 318,300 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 97,125 | 431,800 | SH | SOLE | 431,800 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 46,618 | 5,414,400 | SH | SOLE | 5,414,400 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 14,491 | 1,212,611 | SH | SOLE | 1,212,611 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 325,613 | 1,007,000 | SH | SOLE | 1,007,000 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 1 | 57,770 | SH | SOLE | 57,770 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 5,148 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 8,916 | 698,200 | SH | SOLE | 698,200 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 76,028 | 1,735,000 | SH | SOLE | 1,735,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 197,094 | 1,855,700 | SH | SOLE | 1,855,700 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 23,519 | 1,798,100 | SH | SOLE | 1,798,100 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | 18,609 | 1,414,082 | SH | SOLE | 1,414,082 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 18 | 99,999 | SH | SOLE | 99,999 | 0 | 0 | ||
ONCOSEC MED INC | COM | 68234L306 | 1,437 | 2,945,000 | SH | SOLE | 2,945,000 | 0 | 0 | ||
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 4,900 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 768 | 4,361,365 | SH | SOLE | 4,361,365 | 0 | 0 | ||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 21,127 | 1,906,800 | SH | SOLE | 1,906,800 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 41,385 | 1,981,100 | SH | SOLE | 1,981,100 | 0 | 0 | ||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 21,799 | 2,820,000 | SH | SOLE | 2,820,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 119,259 | 1,967,000 | SH | SOLE | 1,967,000 | 0 | 0 | ||
REUNION NEUROSCIENCE INC | COM | 76134G103 | 851 | 595,200 | SH | SOLE | 595,200 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 45,774 | 2,321,200 | SH | SOLE | 2,321,200 | 0 | 0 | ||
SANGAMO THERAPEUTICS INC | COM | 800677106 | 11,568 | 2,360,800 | SH | SOLE | 2,360,800 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 104,814 | 948,200 | SH | SOLE | 948,200 | 0 | 0 | ||
SCIENCE 37 HOLDINGS INC | COM | 808644108 | 692 | 430,000 | SH | SOLE | 430,000 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 2,737 | 1,140,600 | SH | SOLE | 1,140,600 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 60,958 | 445,500 | SH | SOLE | 445,500 | 0 | 0 | ||
SEASPINE HLDGS CORP | COM | 81255T108 | 11,417 | 2,010,000 | SH | SOLE | 2,010,000 | 0 | 0 | ||
SEMA4 HOLDINGS CORP | COM CL A | 81663L101 | 834 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
SI-BONE INC | COM | 825704109 | 17,402 | 996,700 | SH | SOLE | 996,700 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CP | CLASS A ORD SHS | G8253Y105 | 1,964 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253U103 | 1,960 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 117,394 | 1,480,000 | SH | SOLE | 1,480,000 | 0 | 0 | ||
SPDR SER TR | CALL | 78464A900 | 158,719 | 2,001,000 | SH | Call | SOLE | 2,001,000 | 0 | 0 | |
SPDR SER TR | CALL | 78464A900 | 162,685 | 2,051,000 | SH | Call | SOLE | 2,051,000 | 0 | 0 | |
STOKE THERAPEUTICS INC | COM | 86150R107 | 11,442 | 891,100 | SH | SOLE | 891,100 | 0 | 0 | ||
STRYKER CORPORATION | COM | 863667101 | 37,409 | 184,700 | SH | SOLE | 184,700 | 0 | 0 | ||
SURGERY PARTNERS INC | COM | 86881A100 | 6,262 | 267,600 | SH | SOLE | 267,600 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 134,253 | 5,586,900 | SH | SOLE | 5,586,900 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 5,796 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 2,946 | 813,700 | SH | SOLE | 813,700 | 0 | 0 | ||
TRANSMEDICS GROUP INC | COM | 89377M109 | 12,522 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 84,957 | 2,051,600 | SH | SOLE | 2,051,600 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 203,140 | 970,200 | SH | SOLE | 970,200 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 15,089 | 628,700 | SH | SOLE | 628,700 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 148,476 | 512,800 | SH | SOLE | 512,800 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 35,817 | 1,042,706 | SH | SOLE | 1,042,706 | 0 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 42,203 | 1,234,000 | SH | SOLE | 1,234,000 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 91,472 | 4,223,100 | SH | SOLE | 4,223,100 | 0 | 0 |